| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/12/2014 | EP2694083A2 Peptides and pharmaceutical compositions for use in the treatment by nasal administration of patients suffering from anxiety and sleep disorders |
| 02/12/2014 | EP2694082A1 Use of a hypoallergenic cereal composition for including specific oral tolerance |
| 02/12/2014 | EP2694078A1 Selection of hcv treatment |
| 02/12/2014 | EP2694046A1 Methods and pharmaceutical compositions for inhibiting influenza viruses replication |
| 02/12/2014 | EP2694040A2 Osmotic mediated release synthetic nanocarriers |
| 02/12/2014 | EP2694034A1 Ophthalmic preparations based on pacap (pituitary adenylate cyclase activating polypeptide) which restore the normal visual function in early glaucoma |
| 02/12/2014 | EP2693893A2 Thixotropic -lactalbumin hydrogels, method for preparing same and uses thereof |
| 02/12/2014 | EP2693887A2 Modulating bacterial mam polypeptides in pathogenic disease |
| 02/12/2014 | CN203424255U Collagen particle structure capable of improving skin condition |
| 02/12/2014 | CN103582646A Antiviral agent |
| 02/12/2014 | CN103582492A Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organs |
| 02/12/2014 | CN103582491A Prevention of hypoglycaemia in diabetes mellitus type 2 patients |
| 02/12/2014 | CN103582490A Hepatocyte growth factor mimics as therapeutic agents |
| 02/12/2014 | CN103582489A Compositions and methods for improving prognosis of a human with subarachnoid hemorrhage |
| 02/12/2014 | CN103582488A Use of a hypoallergenic cereal composition for inducing specific oral tolerance |
| 02/12/2014 | CN103571927A Applications of human SAMD9L gene and protein product encoded by human SAMD9L gene |
| 02/12/2014 | CN103571902A Leiocassis longirostris skin collagen antioxidation peptide, and preparation method and application thereof |
| 02/12/2014 | CN103571863A Novel pharmaceutical protein DRACO and applications thereof in prevention and treatment of porcine reproductive and respiratory syndrome |
| 02/12/2014 | CN103571848A Virulence gene of punctate palmoplantar keratodermas and use thereof |
| 02/12/2014 | CN103571814A Sulfhydryl modified recombinant human arginase I, as well as preparation method and application thereof |
| 02/12/2014 | CN103571803A Polypeptide segment, and preparation method and application thereof |
| 02/12/2014 | CN103570834A Methoxy polyethylene glycol-modified erythropoietin mimic peptide derivative |
| 02/12/2014 | CN103570809A Anti-inflammatory lipopeptide as well as preparation method and application for same |
| 02/12/2014 | CN103570808A Alpha-conotoxin peptide TxIB/Txd4, as well as pharmaceutical composition and use thereof |
| 02/12/2014 | CN103570807A Short peptide, preparation method thereof, and applications of the short peptide in diagnosis or treatment of apoA-I related diseases |
| 02/12/2014 | CN103570806A 多肽环氧酮化合物 Peptide epoxy ketone compound |
| 02/12/2014 | CN103566363A Preparation method of contraceptive microneedle |
| 02/12/2014 | CN103566362A Application of recombinant ADAMTS13 to preparation of cerebral hemorrhage medicaments |
| 02/12/2014 | CN103566361A Hand-washing disinfection liquid |
| 02/12/2014 | CN103566360A Mass production of ready-to-use suspensions of fibrinogen-coated albumin spheres for the treatment of thrombocytopenic patients |
| 02/12/2014 | CN103566359A Application of self-made flushing liquid and punching-sucking-type medicine changing method for treatment of diabetic foot |
| 02/12/2014 | CN103566358A New method provided by combination of human umbilical cord mesenchymal stem cells and incretin for improvement of functions of diabetes islet beta cells |
| 02/12/2014 | CN103566357A Application of IL-21 to prepare immunosuppressor |
| 02/12/2014 | CN103566356A Application of human recombinant hepatic stimulator substance in preparing medicine for treating non-alcoholic fatty liver disease |
| 02/12/2014 | CN103566355A Composite lotus root starch preparation |
| 02/12/2014 | CN103566354A Pharmaceutical composition containing derivatives of GLP-1 analogue or medicinal salts thereof |
| 02/12/2014 | CN103566353A Method for constructing asthmatic animal model |
| 02/12/2014 | CN103566352A Novel milk fermentation product and purposes thereof |
| 02/12/2014 | CN103565797A Medicine composition and application for inhibiting autophagy of motor neurons |
| 02/12/2014 | CN103565757A Recombinant human interleukin-2 freeze-dried preparation for injection and preparation method thereof |
| 02/12/2014 | CN103565731A Thymopentin injection composition |
| 02/12/2014 | CN103211065B Pabular health tea electuary for promoting lead excretion |
| 02/12/2014 | CN103191408B Medicine composition and gel for treating colpitis and applications thereof |
| 02/12/2014 | CN103182070B External composition, and preparation and application thereof |
| 02/12/2014 | CN103059124B Recombined porcine interferon Gamma, coding gene thereof and expressing method |
| 02/12/2014 | CN103030687B Anti-inflammatory active peptide Hydrostatin-SN1 derived from Hydrophis cyanocinctus, coding gene thereof and application in pharmacy |
| 02/12/2014 | CN102911257B Cyclic lipopeptide antibiotic and preparation and application thereof |
| 02/12/2014 | CN102816240B Fusion protein and fusion protein expression vector thereof |
| 02/12/2014 | CN102643340B Polypeptide based on human TLR9 receptor functional domain segment LRR11 and application thereof |
| 02/12/2014 | CN102580068B Compound perfusate for treating mammitis of dairy cattle and preparation method thereof |
| 02/12/2014 | CN102512654B Swine aphrodisiac powder preparation and its preparation technology |
| 02/12/2014 | CN101896499B Compositions and methods of using proislet peptides and analogs thereof |
| 02/12/2014 | CN101583371B RNAi methods and compositions for stimulating proliferation of cells with adherent junctions |
| 02/12/2014 | CN101484587B IGF-IR antagonists as adjuvants for treatment of prostate cancer |
| 02/12/2014 | CN101309934B 修饰的伴侣蛋白10 Modified chaperonin 10 |
| 02/11/2014 | US8648186 Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field |
| 02/11/2014 | US8648185 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 02/11/2014 | US8648175 Stable pharmaceutical composition comprising erythropoietin |
| 02/11/2014 | US8648174 Ucp4 |
| 02/11/2014 | US8648171 Members of the FC receptor homolog gene family (FcRH1-3,6) related reagents and uses thereof |
| 02/11/2014 | US8648170 Peptide-presenting surfaces for long-term culture of pluripotent cells |
| 02/11/2014 | US8648169 Methods of use of Trk receptor modulators |
| 02/11/2014 | US8648119 Controlled release immunomodulator compositions and methods for the treatment of otic disorders |
| 02/11/2014 | US8648054 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication |
| 02/11/2014 | US8648048 Methods of providing therapeutic effects using cyclosporin components |
| 02/11/2014 | US8648047 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers |
| 02/11/2014 | US8648046 Compositions and methods for visualizing and eliminating cancer stem cells |
| 02/11/2014 | US8648045 VDAC1 compositions and methods of use thereof for regulating apoptosis |
| 02/11/2014 | US8648044 FKBP52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction |
| 02/11/2014 | US8648043 Method of reducing injury to mammalian cells |
| 02/11/2014 | US8648042 Pharmaceutical compositions |
| 02/11/2014 | US8648041 Double-acylated GLP-1 derivatives |
| 02/11/2014 | US8648040 Amino acid composition for improving glucose tolerance |
| 02/11/2014 | US8648039 Use of alpha-lactalbumin for regulations of glycemia |
| 02/11/2014 | US8648038 (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| 02/11/2014 | US8648037 Macrocyclic proline derived HCV serine protease inhibitors |
| 02/11/2014 | US8648036 Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract |
| 02/11/2014 | US8648034 Method and applications of peptide-mediated mitochondrial delivery system |
| 02/11/2014 | US8647868 Compositions and methods for increasing production of recombinant gamma-carboxylated proteins |
| 02/11/2014 | US8647866 ZCYTOR17 heterodimeric cytokine receptor polynucleotides |
| 02/11/2014 | US8647842 Methods for producing a fusion protein capable of binding VEGF |
| 02/11/2014 | US8647831 Cobalamin assay |
| 02/11/2014 | US8647826 Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer |
| 02/11/2014 | US8647820 Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription |
| 02/11/2014 | US8647687 Isoamyl acetate for weight management |
| 02/11/2014 | US8647663 Wound healing device comprising sutures or knitted mesh embedded with a wound healing composition |
| 02/11/2014 | US8647662 Wound healing device comprising a cloth embedded with a wound healing composition |
| 02/11/2014 | US8647657 Polymeric devices for controlled release of active agents |
| 02/11/2014 | US8647632 Proteins |
| 02/11/2014 | US8647631 Pharmaceutical composition of an antigenic tau peptide reconstituted in a liposome and related antibodies and cell lines |
| 02/11/2014 | US8647630 Mite allergen |
| 02/11/2014 | US8647629 Powerful MHC-class II peptides derived from survivin |
| 02/11/2014 | US8647628 Peptide epitopes of apolipoprotein B |
| 02/11/2014 | US8647627 Composition for a cancer vaccine |
| 02/11/2014 | US8647620 Chimeric factor VII molecules |
| 02/11/2014 | US8647619 Osteogenesis promoter |
| 02/11/2014 | US8647617 Methods for modulating inflammatory and/or immune responses |
| 02/11/2014 | CA2631343C The combination of omega-3 fatty acids and thyroid hormone for treating alzheimer's dementia |
| 02/11/2014 | CA2575610C Hpv vaccine comprising peptides from host cell proteins |
| 02/11/2014 | CA2574085C Gonadotropin releasing hormone antagonists |